Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Pollak

Showing results (11-20 of 175) with videos related to

Pageof 18
Sort By:
Journal of the National Cancer Institute|June 19, 2003
Re: Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk womenRupa Narasimhadevara, Michael N Pollak, William D Foulkes
Nature Reviews. Cancer|July 2, 2004
Insulin-like growth factors and neoplasiaMichael N Pollak, Eva S Schernhammer, Susan E Hankinson
Nature Reviews. Clinical Oncology|August 10, 2016
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?Adi J Klil-Drori, Laurent Azoulay, Michael N Pollak
Cancer Prevention Research (Philadelphia, Pa.)|April 4, 2020
Cancer Immunoprevention: A Case Report Raising the Possibility of "Immuno-interception"Jessica G Mancuso, William D Foulkes, Michael N Pollak
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2002
Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrationsMichelle D Holmes, Michael N Pollak, Susan E Hankinson
Breast Cancer Research and Treatment|February 6, 2010
Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cellsMahvash Zakikhani, Marie-José Blouin, Esther Piura, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 15, 2014
The use of metformin in patients with prostate cancer and the risk of deathLeah Bensimon, Hui Yin, Samy Suissa, et al.
International Journal of Cancer|November 15, 2005
Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, CanadaMarie-Claude Rousseau, Marie-Elise Parent, Michael N Pollak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2013
The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitusBrielan Smiechowski, Laurent Azoulay, Hui Yin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinaseMahvash Zakikhani, Ryan J O Dowling, Nahum Sonenberg, et al.
Pageof 18

Showing results (11-20 of 175) with videos related to

Sort By:
Pageof 18
Journal of the National Cancer Institute|June 19, 2003
Re: Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk womenRupa Narasimhadevara, Michael N Pollak, William D Foulkes
Nature Reviews. Cancer|July 2, 2004
Insulin-like growth factors and neoplasiaMichael N Pollak, Eva S Schernhammer, Susan E Hankinson
Nature Reviews. Clinical Oncology|August 10, 2016
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?Adi J Klil-Drori, Laurent Azoulay, Michael N Pollak
Cancer Prevention Research (Philadelphia, Pa.)|April 4, 2020
Cancer Immunoprevention: A Case Report Raising the Possibility of "Immuno-interception"Jessica G Mancuso, William D Foulkes, Michael N Pollak
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2002
Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrationsMichelle D Holmes, Michael N Pollak, Susan E Hankinson
Breast Cancer Research and Treatment|February 6, 2010
Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cellsMahvash Zakikhani, Marie-José Blouin, Esther Piura, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 15, 2014
The use of metformin in patients with prostate cancer and the risk of deathLeah Bensimon, Hui Yin, Samy Suissa, et al.
International Journal of Cancer|November 15, 2005
Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, CanadaMarie-Claude Rousseau, Marie-Elise Parent, Michael N Pollak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 23, 2013
The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitusBrielan Smiechowski, Laurent Azoulay, Hui Yin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinaseMahvash Zakikhani, Ryan J O Dowling, Nahum Sonenberg, et al.
Pageof 18